Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-12-22
DOI
10.1016/j.apsb.2020.12.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia
- (2020) Xin He et al. BLOOD
- Cancer antigen discovery is enabled by RNA-sequencing of highly purified malignant and non-malignant cells
- (2020) Martin J Scurr et al. CLINICAL CANCER RESEARCH
- Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells
- (2020) Renier Myburgh et al. LEUKEMIA
- Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward
- (2020) Leila Jafarzadeh et al. Frontiers in Immunology
- Eradication of neuroblastoma by T cells redirected with an optimized GD2-specific chimeric antigen receptor and interleukin-15
- (2019) Yuhui Chen et al. CLINICAL CANCER RESEARCH
- Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
- (2019) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
- (2019) Junhui Hu et al. Stem Cells International
- Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
- (2019) Mohamed-Reda Benmebarek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors
- (2019) Anna Schurich et al. Immunotherapy
- Preclinical Evaluation of Chimeric Antigen Receptor–Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer
- (2019) Bing-Lan Zhang et al. HUMAN GENE THERAPY
- Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
- (2019) Shivani Srivastava et al. CANCER CELL
- Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells
- (2019) Esther Drent et al. CLINICAL CANCER RESEARCH
- Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
- (2019) Yitian Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
- (2019) Lynsey M. Whilding et al. Cancers
- Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
- (2019) Yazdanifar et al. Cells
- A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor positive cells
- (2019) Marco Ruella et al. BLOOD
- Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells
- (2019) Shinkichi Morita et al. CANCER LETTERS
- Rituximab as a therapeutic option for patients with advanced melanoma
- (2018) Julia K. Winkler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts
- (2018) Ping-Pin Zheng et al. DRUG DISCOVERY TODAY
- Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells
- (2018) Bian Hu et al. HUMAN GENE THERAPY
- Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T
- (2018) Dok Yoon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MALAT1 modulates the autophagy of retinoblastoma cell through miR-124-mediated stx17 regulation
- (2018) Jun Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
- (2018) Jinghua Wang et al. Journal of Hematology & Oncology
- Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
- (2018) S. Haubner et al. LEUKEMIA
- Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment
- (2018) Yasuyuki Arai et al. MOLECULAR THERAPY
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Antagonizing CD105 enhances radiation sensitivity in prostate cancer
- (2018) Anisha Madhav et al. ONCOGENE
- Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T Cells
- (2018) Na An et al. MOLECULAR PHARMACEUTICS
- Poly(ethylene glycol)–poly(lysine) block copolymer–ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells
- (2018) Reishi Toshiyama et al. ONCOGENE
- Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia
- (2018) Linde M. Morsink et al. BLOOD REVIEWS
- LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients
- (2018) Yuan Xie et al. JOURNAL OF PATHOLOGY
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion
- (2018) Annette Künkele et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies
- (2017) Alexandra Martyniszyn et al. HUMAN GENE THERAPY
- Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor–Based Immunotherapy and Chemotherapy
- (2017) Rüdiger Klapdor et al. HUMAN GENE THERAPY
- Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia
- (2017) Eduardo Laborda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
- (2017) Kai-chao Feng et al. Journal of Hematology & Oncology
- A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization
- (2017) Esther Drent et al. MOLECULAR THERAPY
- Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
- (2017) Haruko Tashiro et al. MOLECULAR THERAPY
- Visualization and targeting of LGR5+ human colon cancer stem cells
- (2017) Mariko Shimokawa et al. NATURE
- CD20 role in pathophysiology of Hodgkin’s disease
- (2017) Marcelo Antônio Oliveira Santos et al. Revista da Associacao Medica Brasileira
- Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
- (2017) Wei Xia Ang et al. Oncotarget
- Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
- (2017) Yelei Guo et al. Protein & Cell
- The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
- (2017) T Redmer et al. Oncogenesis
- Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
- (2017) Liang Liu et al. Frontiers in Immunology
- Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
- (2017) Yaya Chu et al. OncoImmunology
- CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
- (2017) Thivyan Thayaparan et al. OncoImmunology
- CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
- (2017) Vita Golubovskaya et al. Cancers
- The cancer stem-cell signaling network and resistance to therapy
- (2016) A. Carnero et al. CANCER TREATMENT REVIEWS
- Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
- (2016) E. Drent et al. HAEMATOLOGICA
- A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma
- (2016) MASAFUMI YAMASHITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity
- (2016) R C Lynn et al. LEUKEMIA
- LGR5-Targeted Antibody–Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence
- (2016) Xing Gong et al. MOLECULAR CANCER THERAPEUTICS
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts
- (2016) Michael Ngo et al. Cell Reports
- CD133, Selectively Targeting the Root of Cancer
- (2016) Jörg Schmohl et al. Toxins
- Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
- (2016) E. Drent et al. HAEMATOLOGICA
- Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization
- (2016) K. Newick et al. Cancer Immunology Research
- Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery
- (2016) Annacarmen Petrizzo et al. Scientific Reports
- Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
- (2015) Soranobu Ninomiya et al. BLOOD
- Targeting of folate receptor on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells
- (2015) R. C. Lynn et al. BLOOD
- Over-expressing Akt in T cells to resist tumor immunosuppression and increase anti-tumor activity
- (2015) Yanhong Wu et al. BMC CANCER
- Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- (2015) Zhenling Deng et al. BMC IMMUNOLOGY
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
- (2015) Rachel A. Burga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression
- (2015) Yoshikane Kikushige et al. Cell Stem Cell
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice
- (2015) Heather VanSeggelen et al. MOLECULAR THERAPY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
- (2015) Drew C. Deniger et al. PLoS One
- Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
- (2015) Melissa R. Junttila et al. Science Translational Medicine
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling
- (2015) Lu Yang et al. STEM CELLS
- Engineering CAR-T cells: Design concepts
- (2015) Shivani Srivastava et al. TRENDS IN IMMUNOLOGY
- The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas
- (2015) Y. Komohara et al. Cancer Immunology Research
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells
- (2015) Max Schlaak et al. Oncotarget
- CD271 is an imperfect marker for melanoma initiating cells
- (2015) Yann Cheli et al. Oncotarget
- Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
- (2015) Xuekai Zhu et al. Oncotarget
- Advances in patient-derived tumor xenografts: From target identification to predicting clinical response rates in oncology
- (2014) Edward Rosfjord et al. BIOCHEMICAL PHARMACOLOGY
- Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
- (2014) S. Gill et al. BLOOD
- Cancer stem cells - important players in tumor therapy resistance
- (2014) Selcuk Colak et al. FEBS Journal
- Diverse Solid Tumors Expressing a Restricted Epitope of L1-CAM Can Be Targeted by Chimeric Antigen Receptor Redirected T Lymphocytes
- (2014) Hao Hong et al. JOURNAL OF IMMUNOTHERAPY
- Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
- (2014) I Pizzitola et al. LEUKEMIA
- Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
- (2014) P. S. Adusumilli et al. Science Translational Medicine
- Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
- (2013) Sarah Tettamanti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Simultaneous Targeting of Tumor Antigens and the Tumor Vasculature Using T Lymphocyte Transfer Synergize to Induce Regression of Established Tumors in Mice
- (2013) D. Chinnasamy et al. CANCER RESEARCH
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
- (2013) L. B. John et al. CLINICAL CANCER RESEARCH
- HLA ligandome tumor antigen discovery for personalized vaccine approach
- (2013) Hans-Georg Rammensee et al. Expert Review of Vaccines
- Multiple myeloma-initiating cells
- (2013) Naoki Hosen INTERNATIONAL JOURNAL OF HEMATOLOGY
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
- (2013) Madhusudhanan Sukumar et al. JOURNAL OF CLINICAL INVESTIGATION
- CD271 on Melanoma Cell Is an IFN-γ-Inducible Immunosuppressive Factor that Mediates Downregulation of Melanoma Antigens
- (2013) Junpei Furuta et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Plasma Membrane Proteomics of Tumor Spheres Identify CD166 as a Novel Marker for Cancer Stem-like Cells in Head and Neck Squamous Cell Carcinoma
- (2013) Ming Yan et al. MOLECULAR & CELLULAR PROTEOMICS
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity
- (2013) Yujie Liu et al. NATURE MEDICINE
- Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma
- (2013) Lihua E. Budde et al. PLoS One
- PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
- (2013) V. D. Fedorov et al. Science Translational Medicine
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Understanding cancer stem cell heterogeneity and plasticity
- (2012) Dean G Tang CELL RESEARCH
- Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer
- (2012) A. J. Ziebarth et al. CLINICAL CANCER RESEARCH
- Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
- (2012) S. Julien et al. CLINICAL CANCER RESEARCH
- Discrete nature of EpCAM+and CD90+cancer stem cells in human hepatocellular carcinoma
- (2012) Taro Yamashita et al. HEPATOLOGY
- Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN- and GM-CSF
- (2012) P. Spear et al. JOURNAL OF IMMUNOLOGY
- Targeting CD20 in Melanoma Patients at High Risk of Disease Recurrence
- (2012) Alice Pinc et al. MOLECULAR THERAPY
- Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells
- (2012) Jing Jiao et al. PLoS One
- The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles
- (2011) Yang Zhang et al. BIOMATERIALS
- Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells
- (2011) Guan-Nan Zhang et al. CANCER LETTERS
- Genetically Modified T cells Targeting Interleukin-11 Receptor -Chain Kill Human Osteosarcoma Cells and Induce the Regression of Established Osteosarcoma Lung Metastases
- (2011) G. Huang et al. CANCER RESEARCH
- Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
- (2011) M. Hong et al. CANCER RESEARCH
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
- (2011) E. K. Moon et al. CLINICAL CANCER RESEARCH
- L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
- (2011) Lin Cheng et al. EMBO JOURNAL
- c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
- (2011) Chenwei Li et al. GASTROENTEROLOGY
- The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC- II depletion
- (2011) V. Biberacher et al. HAEMATOLOGICA
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
- (2011) Ilona Kryczek et al. INTERNATIONAL JOURNAL OF CANCER
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Eradication of melanomas by targeted elimination of a minor subset of tumor cells
- (2011) P. Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
- (2011) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia
- (2010) Q. Zhou et al. BLOOD
- The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
- (2010) M. Hudecek et al. BLOOD
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
- (2010) John A. Craddock et al. JOURNAL OF IMMUNOTHERAPY
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
- (2010) Alexander D. Boiko et al. NATURE
- T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
- (2009) A. Di Stasi et al. BLOOD
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
- (2009) Liqing Jin et al. Cell Stem Cell
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- CD38 is constitutively expressed in the nucleus of human hematopoietic cells
- (2008) M. Orciani et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now